
    
      Eligible criteria include Chinese males, aged between 40 and 69 years old, with T2DM with a
      HbA1c of 7.1 to 12% and who have been on a stable oral hypoglycemic regimen for the past 3
      months. Subjects who were insulin-dependent, with renal or liver impairment or who were
      terminally ill were excluded.
    
  